Clinical trial
Paroxysmal Atrial Fibrillation Prognosis Based on Cardiopulmonary Exercise Test Data and Novel Echocardiographic and Plasma Biochemical Indices (the PLACEBO Trial)
NCT05246423 is registered in ClinicalTrials.gov with Aristotle University Of Thessaloniki as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Paroxysmal Atrial Fibrillation Prognosis Based on Cardiopulmonary Exercise Test Data and Novel Echocardiographic and Plasma Biochemical Indices (the PLACEBO Trial)
- Lead sponsor
- Aristotle University Of Thessaloniki
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- December 10, 2020
- Completion date
- December 10, 2024
- Enrollment
- 80 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
atrial arrhythmia, atrial fibrillation